Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: June 2016

CAS Medical Systems, Inc. (CASM) Starts Presentation at LD Micro Invitational Conference

CAS Medical Systems (NASDAQ: CASM) is a leader in non-invasive patient monitoring of cerebral oxygenation. The company’s FORE-SIGHT Absolute Cerebral Oximeter provides a highly accurate, non-invasive, continuous measurement of absolute cerebral tissue oxygen saturation for patients during critical care. Direct monitoring … Continue reading

Posted in LD Micro Conference | Leave a comment

Resonant, Inc. (RESN) Starts Presentation at LD Micro Invitational Conference

Resonant (NASDAQ: RESN) is a late-stage development company creating innovative filter designs for radio frequency front-ends (RFFEs) for the mobile device industry. The RFFE is the circuitry in a mobile device responsible for analog signal processing. Filters are a critical … Continue reading

Posted in LD Micro Conference | Leave a comment

Dataram Corp. (DRAM) Starts Presentation at LD Micro Invitational Conference

Dataram (NASDAQ: DRAM) is an independent manufacturer of memory products and provider of performance solutions that increase the performance and extend the useful life of servers, workstation, desktops and laptops sold by leading manufacturers. Dataram’s memory products and solutions are … Continue reading

Posted in LD Micro Conference | Leave a comment

Sysorex Global (SYRX) Starts Presentation at LD Micro Invitational Conference

Sysorex (NASDAQ: SYRX) develops systems and solutions that power the data-driven enterprise. The company blends virtual data from software and networks with the huge volume of physical data generated by mobile devices and Internet-connected things to open new worlds of … Continue reading

Posted in LD Micro Conference | Leave a comment

Signal Genetics, Inc. (SGNL) Starts Presentation at LD Micro Invitational Conference

Signal Genetics (NASDAQ: SGNL) is a commercial-stage molecular design company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer. The company’s lead product is its MyPRS® test, which … Continue reading

Posted in LD Micro Conference | Leave a comment

Biolase, Inc. (BIOL) Starts Presentation at LD Micro Invitational Conference

Biolase (NASDAQ: BIOL) is a medical device company that develops, manufactures, markets and sells laser systems for dentistry and medicine and also markets, sells and distributes dental imaging equipment. The company’s proprietary laser products incorporate approximately 250 patented and 90 … Continue reading

Posted in LD Micro Conference | Leave a comment

Delcath Systems, Inc. (DCTH) Starts Presentation at LD Micro Invitational Conference

Delcath Systems (NASDAQ: DCTH) is a specialty pharmaceutical and medical device company focused on oncology and the treatment of primary and metastatic liver cancers. The company’s proprietary Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS) … Continue reading

Posted in LD Micro Conference | Leave a comment

FTE Networks, Inc. (FTNW) Starts Presentation at LD Micro Invitational Conference

FTE Networks (OTC: FTNW), together with its subsidiaries, provides international and regional telecommunications and technology systems, and infrastructure services. The company specializes in the design, engineering, installation and maintenance of various forms of telecommunications infrastructure, also provides wireless solutions to … Continue reading

Posted in LD Micro Conference | Leave a comment

CV Sciences, Inc. (CANV) Starts Presentation at LD Micro Invitational Conference

CV Sciences (OTC: CANV) focuses on drug development activities on products containing the hemp plant extract cannabidiol (CBD) as the active pharmaceutical ingredient, and also is engaged in the sale of CBD, and the development, marketing and sale of end … Continue reading

Posted in LD Micro Conference | Leave a comment

Buy One get One Free with International Stem Cell Corporation (ISCO)

The recent initiation report on International Stem Cell Corporation (OTCQB: ISCO) by Edison Investment Research looks at the company from a novel perspective. Although described as ‘an early-stage cell therapy company currently in Phase I/IIa clinical trials to treat Parkinson’s … Continue reading

Posted in International Stem Cell Corp. ISCO | Leave a comment